In the food industry, reducing sugar while maintaining taste is one of the most difficult formulation challenges. Consumers increasingly want products with lower sugar, added fiber, digestive health benefits, and cleaner ingredient labels.
For food manufacturers, achieving those goals without affecting texture, sweetness, or production costs often requires specialized ingredients rather than simple sugar substitutes.
Hyderabad-based Revelations Biotech is one of the Indian companies working in this area. Founded in 2008, the company develops prebiotics, probiotics, enzymes, and functional food ingredients for food, feed, nutraceutical, and pharmaceutical applications. Rather than selling consumer products directly, Revelations primarily operates as an ingredient technology company supplying food and nutrition manufacturers.
The company was founded by Dr. Ravi Chandra Beeram, a molecular biologist and structural biologist who earned his PhD from the International Centre for Genetic Engineering and Biotechnology (ICGEB) in New Delhi. Before starting the company, Beeram worked as a crystallographer and structure-guided drug design scientist in the contract research industry. He has worked extensively on protein engineering, molecular biology, and X-ray crystallography, solving more than 200 co-crystal structures related to drug targets.
Revelations began as an incubated biotechnology venture at IKP Knowledge Park in Hyderabad. Later, entrepreneur and business leader C.V. Subba Rao joined the company to help scale operations and commercialization.
Revelations Biotech has raised approximately $2.5 million across three seed funding rounds, with investors including Foraysoft, Evolve Venture Capital, and Narla Family Living Trust.
The core of Revelations’ business revolves around functional ingredients that can be incorporated into foods, beverages, animal feed, and health products. Among its most prominent products is FOSLIFE®, a fructooligosaccharide (FOS) ingredient manufactured from cane sugar. Fructooligosaccharides are short-chain carbohydrates that function as prebiotic fibers. Unlike regular sugar, they are not fully digested in the upper digestive system. Instead, they reach the colon, where they serve as food for beneficial gut bacteria.
What makes FOS interesting for food manufacturers is that it can contribute sweetness while also adding fiber. According to Revelations, FOSLIFE provides roughly 70 percent of the sweetness of conventional sugar while delivering prebiotic benefits. This allows manufacturers to reduce sugar content in products without entirely sacrificing taste. The ingredient is positioned for use in bakery products, beverages, dairy products, confectionery, nutrition bars, and functional foods.
The company’s work is not limited to human nutrition. Revelations also produces FOSGRO™, a prebiotic ingredient designed for animal nutrition. The product is marketed for poultry feed, cattle feed, aquaculture feed, and pet food applications.
Another major part of the business involves enzyme manufacturing. Enzymes act as biological catalysts that help industrial processes run more efficiently. Revelations produces enzymes including fungal amylase, glucoamylase, invertase, and beta-galactosidase. These enzymes are used in industries such as food processing, starch conversion, brewing, dairy manufacturing, and feed production. According to the company, it has developed proprietary enzyme production platforms optimized for large-scale manufacturing.
The scientific infrastructure behind these products is a significant part of the company’s positioning. Revelations states that it combines molecular biology, enzyme engineering, microbiology, fermentation technology, structural biology, artificial intelligence, and directed evolution techniques in product development. Directed evolution is a laboratory method where enzymes are repeatedly modified and screened to improve performance characteristics such as stability, efficiency, or temperature tolerance. Instead of relying on naturally occurring enzymes, researchers create multiple variants and identify those that perform better under industrial conditions.
The company operates research laboratories integrated with pilot-scale production facilities. According to Revelations, this allows new technologies to move more quickly from laboratory testing into commercial manufacturing. The company has also disclosed research collaborations with organizations including CSIR-IMTECH, the Translational Health Science and Technology Institute (THSTI), the Institute of Chemical Technology (ICT Mumbai), and Drug Discovery Research Center (DDRC). [Company website]
Commercial deployment appears to be concentrated in the ingredient supply chain rather than visible consumer-facing products. The company states that it works with major food companies globally to provide sugar reduction, fiber enrichment, and gut-health solutions.
The broader market in which Revelations operates has expanded significantly over the last decade. Consumer demand for reduced-sugar products, digestive health ingredients, and functional foods has driven rapid growth in the global prebiotics sector. Ingredient companies including BENEO, Ingredion, Tate & Lyle, FrieslandCampina Ingredients, and Sensus have all invested heavily in prebiotic fiber products. These companies typically focus on ingredients such as inulin, oligofructose, galactooligosaccharides, and fructooligosaccharides.
In Asia, particularly India, the category is receiving additional attention because diabetes, obesity, and metabolic health concerns are increasing demand for products with lower sugar content. Food manufacturers are searching for ingredients that can reduce sugar while maintaining taste, texture, and consumer acceptance. Prebiotic fibers are increasingly being positioned as one way to address multiple formulation goals simultaneously.
- Our correspondent
